United States

SHERIDAN, WYOMING -- June 25, 2026 -- General Motors senior vice president of global manufacturing Mike Trevorrow has outlined the scale of GM's current U.S. manufacturing commitment, citing $9 billion in American plant and facilities investment in 2026 alongside $7 billion in domestic research and development. Writing as the United States approaches its 250th anniversary, Trevorrow frames the spending not as a one-time commitment but as the infrastructure necessary to scale advanced technology through skilled workers, supply chains and local economic ecosystems. GM employs one in every 10 American autoworkers and contributed nearly $50 billion to U.S. GDP in 2025.

SHERIDAN, WYOMING -- June 25, 2026 -- Cadillac Racing has been named winner of the 2026 DHL Sustainable Endurance Award in the Hypercar category, a recognition presented by the FIA, ACO and DHL in connection with the 24 Hours of Le Mans. The award acknowledges a structured sustainability program spanning race logistics, hospitality, waste reduction, procurement and community engagement. Judges cited Cadillac Racing's submission as one of the most complete and measurable dossiers received in this year's competition, with every element tied directly to Le Mans race operations.

SHERIDAN, WYOMING -- June 25, 2026 -- General Motors has published details of EMWU, an offboard data pipeline designed to extract rare, safety-critical driving scenarios from millions of miles of autonomous vehicle fleet footage without proportional increases in compute cost. GM's autonomous vehicle fleet generates continuous sensor and camera streams across hundreds of test vehicles, and the volume of that data has made brute-force AI analysis economically and technically unworkable. EMWU separates the problem into three distinct tiers — domain projection, candidate retrieval, and deep visual reasoning — each calibrated to spend compute only where it is warranted.

SHERIDAN, WYOMING — June 17, 2026 — JMF Motorsports secured its first overall race victory of the season Sunday at Michelin Raceway Road Atlanta, fielding the No. 27 Mercedes-AMG GT3 with co-drivers Jason Daskalos and Philip Ellis. The win, built on a pre-race decision to start the wet three-hour race on slick tires, made JMF and Mercedes-AMG the first team-and-manufacturer combination to score overall GT World Challenge America victories with two different cars in the series' new three-hour race format. Daskalos led the opening hour before Ellis, a late call-up replacing regular co-driver Lorcan Hanafin, closed out the race by passing teammate Mikael Grenier's sister entry with under 20 minutes remaining. The result keeps Mercedes-AMG's customer racing program at the front of both the Pro-Am and Pro class standings heading into the series' summer break.

SHERIDAN, WYOMING -- June 15, 2026 -- Roche has received FDA approval for the VENTANA PTEN (SP218) RxDx Assay, the first immunohistochemistry companion diagnostic cleared to assess PTEN protein loss in patients with prostate adenocarcinoma. The assay identifies patients whose tumours exhibit PTEN deficiency, making them potentially eligible for treatment with AstraZeneca's TRUQAP in combination with abiraterone acetate. Approval is based on results from the CAPItello-281 clinical study, where the assay served as the enrollment diagnostic to identify patients with PTEN-deficient tumours.

SHERIDAN, WYOMING -- June 15, 2026 -- The U.S. Food and Drug Administration has accepted Roche's supplemental Biologics License Application for Tecentriq and Tecentriq Hybreza in combination with chemotherapy as an adjuvant treatment for stage III dMMR/MSI-H colon cancer following surgery. The FDA has granted Priority Review and is expected to issue a decision by October 9, 2026. The filing is supported by Phase III ATOMIC study data showing a 50% reduction in the risk of disease recurrence or death compared to chemotherapy alone, results published in The New England Journal of Medicine.

SHERIDAN, WYOMING - May 22, 2026 - Stellantis is expanding its strategic collaboration with Applied Intuition to accelerate development of the STLA Brain intelligent vehicle platform and broaden software capabilities across its vehicle portfolio. The expanded agreement extends the companies' existing work on STLA SmartCockpit into core vehicle software systems, including Vehicle OS, autonomy systems and cabin intelligence technologies. Stellantis said the collaboration is intended to improve software development, simulation, validation and deployment across vehicle programs while supporting faster feature delivery and continuous platform improvement. The initiative reflects the automotive sector's increasing reliance on centralized software architectures and AI-defined vehicle systems to manage performance, connectivity and customer experience at scale.

SHERIDAN, WYOMING - May 13, 2026 - Dentsply Sirona and the American Association for Dental, Oral, and Craniofacial Research (AADOCR) have announced the winners of the 2026 Student Competition for Advancing Dental Research and its Application (SCADA) Awards, recognizing pre-doctoral dental students for research excellence across clinical and basic science disciplines. The awards were presented during the 55th Annual Meeting of AADOCR, held in conjunction with the 104th General Session and Exhibition of the IADR and the 50th Annual Meeting of the Canadian Association for Dental Research, at the San Diego Convention Center from March 25 to 28, 2026. This year's competition drew 61 dental students from across the United States and seven international finalists from Canada, France, Thailand, Taiwan, South Korea, and Japan.

SHERIDAN, WYOMING - May 13, 2026 - TuHURA Biosciences, Inc. (NASDAQ: HURA), a Phase 3 immuno-oncology company focused on overcoming resistance to cancer immunotherapy, has confirmed that President and Chief Executive Officer James A. Bianco, M.D., will participate in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference in New York City on May 19, 2026, at 2:00 pm ET. The appearance gives institutional investors and sector analysts direct access to leadership at a moment when TuHURA is running an active Phase 3 registration trial and advancing two additional pipeline programs. For stakeholders tracking immuno-oncology development timelines and clinical positioning, the session represents a structured opportunity to assess the company's near-term milestones.

SHERIDAN, WYOMING - April 4, 2026 - Dental clinicians managing deep cavity restorations and endodontic retreatment decisions now have a richer evidence base to draw from, as Septodont USA's February 2026 clinical newsletter consolidates two-year trial outcomes for BioRoot® Flow and four documented case studies applying Biodentine® in the Bio-Bulk Fill technique for indirect restorations.

Biodentine Bio-Bulk Fill: four clinical cases document deep cavity restoration

Septodont's Case Studies Collection 28 presents workflows from four clinicians who used Biodentine®'s dentine-like mechanical and biological properties to restore deep cavities using the Bio-Bulk Fill technique. The cases extend the application of the material to symptomatic cracked teeth - a notoriously difficult clinical scenario where pulp status is uncertain and cavity geometry is irregular.